We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

World’s First COVID-19 Drug Based on Human Immunoglobulin Developed from Plasma of Recovered Patients

By HospiMedica International staff writers
Posted on 14 Sep 2021
Illustration
Illustration
The world’s first drug based on human immunoglobulin being developed from plasma of recovered patients could be effective on COVID-19 patients with mild conditions.

China National Pharmaceutical Group Co., Ltd. (Sinopharm Beijing, China) is developing two medicines for the treatment of COVID-19 based on human immunoglobulin and monoclonal antibody. Both the drugs could reduce the impact of the novel coronavirus in infected people and will be effective on patients with mild COVID-19, according to a report by the Global Times.

The first drug being developed from plasma of recovered COVID-19 patients or vaccinated uninfected people contains high-potency SARS-COV-2 neutralizing antibodies. The drug has demonstrated significant relief of symptoms and damage caused by SARS-COV-2 in pre-clinical studies and animal tests. The new drug containing a high level of neutralizing antibodies to the novel coronavirus is all set to soon enter Phase 3 clinical trials.

The second COVID-19 drug under development is based on a potent monoclonal antibody against the Delta variant discovered by researchers at Sinopharm. The monoclonal antibody is capable of effectively blocking the binding of the novel coronavirus to the Angiotensin-converting enzyme 2 which is attached to the membranes of cells located in the intestines, kidney, testes, gallbladder and heart. According to Sinopharm, the antibody can prevent the SARS-COV-2 virus from infecting human cells.

Related Links:
China National Pharmaceutical Group Co., Ltd.

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Blood Pressure Monitor
Cuff Blood Pressure Monitor

Channels

Critical Care

view channel
Image: A demonstration of the PLUME device (Photo courtesy: Dr. Andy Shrimpton / University of Bristol)

Scotland Adopts Respiratory Infection Control Guidance Informed by Aerosol Research

Preventing respiratory infection transmission in hospitals remains a core patient and staff safety priority. Many precautions have hinged on the assumption that certain clinical interventions create high-risk... Read more

Surgical Techniques

view channel
Image: VERAFEYE is an ultrasound-based cardiac visualization and navigation platform that provides a 360-degree view of cardiac structures and devices around the catheter (Photo courtesy of LUMA Vision)

FDA Clears Integrated Platform for Real-Time Cardiac Imaging and Catheter Guidance

Catheter-based treatment of cardiac arrhythmias relies on precise, real-time visualization and navigation for safe, accurate therapy delivery. Yet electrophysiology teams often use separate imaging, mapping,... Read more

Medical Imaging

view channel
Image: A new study compared three deep learning methods to determine which most accurately delineates stroke lesions on contrast-free MRI in routine clinical imaging (Image Credit: iStock)

AI Models Evaluated for Spotting Ischemic Stroke Lesions on Routine MRI

Rapid detection of ischemic stroke on brain MRI is essential because treatment benefit declines with time. Many centers first acquire contrast-free MRI FLAIR sequences because they are quick and broadly... Read more

Business

view channel
Image: The da Vinci SP system enables single-incision or natural-orifice procedures, enhancing visualization and precision in narrow or deep anatomical spaces (Photo courtesy of Intuitive)

Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures

Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more